Safety and Glycemic Outcomes During the MiniMed™ Advanced Hybrid Closed-Loop System Pivotal Trial in Adolescents and Adults with Type 1 Diabetes.

Anders L. Carlson,Jennifer L. Sherr,Dorothy I. Shulman,Satish K. Garg,Rodica Pop-Busui,Bruce W. Bode,David R Lilenquist,Ron Brazg,Kevin B. Kaiserman,Mark Kipnes,James R Thasher,John C. Reed,Robert H. Slover,Athena Philis-Tsimikas,Mark P. Christiansen,Benyamin Grosman,Anirban Roy,Melissa Vella,Richard A. M. Jonkers,Xiaoxiao Chen,John H. Shin,Toni L. Cordero,Scott W. Lee,Andrew S Rhinehart,Robert A. Vigersky

Safety and Glycemic Outcomes During the MiniMed™ Advanced Hybrid Closed-Loop System Pivotal Trial in Adolescents and Adults with Type 1 Diabetes.

2021

Introduction: This trial assessed safety and effectiveness of an advanced hybrid closed-loop (AHCL) system with automated basal (Auto Basal) and automated bolus correction (Auto Correction) in adol...

Keywords:

Type 1 diabetes
Medicine
closed loop
basal
Glycemic
Cardiology
Bolus (digestion)
Internal medicine
Diabetes mellitus

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations